Gilteritinib
In vial of 1 g net
TargetMol Chemicals Inc.
Product Overview
Product / Grade Name
Gilteritinib
Maker Name
Product Description
Gilteritinib (ASP2215) is a potent inhibitor of FMS-related tyrosine kinase 3 (FLT3) and AXL tyrosine kinase receptors (IC50 = 0.29 nM and <1 nM, respectively). In preclinical studies, gilteritinib demonstrated strong antileukemic and antitumor effects. Gilteritinib is currently in several Phase 3 clinical trials for acute myeloid leukemia.
Hazard Classification
UN Number
:IMGD Class
:Packing Group
:
Visual Overview
Corporate Video